You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Brazil Patent: PI0610359


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0610359

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,709,517 Aug 13, 2027 Astellas XTANDI enzalutamide
8,183,274 Aug 24, 2026 Astellas XTANDI enzalutamide
9,126,941 May 15, 2026 Astellas XTANDI enzalutamide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Brazil Patent BRPI0610359: Scope, Claims, and Patent Landscape

Last updated: July 30, 2025

Introduction

Brazilian patent BRPI0610359, issued by the Instituto Nacional da Propriedade Industrial (INPI), plays a pivotal role in the pharmaceutical patent landscape within Brazil. This patent, classified under pharmaceutical innovations, encompasses specific claims and technical scopes that influence market competition, licensing opportunities, and legal enforceability. This analysis offers a detailed examination of its scope, claims, and its positioning within the broader patent environment in Brazil's pharmaceutical sector.


Patent Overview: BRPI0610359

Title: [Exact patent title, e.g., "Pharmaceutical Composition for the Treatment of Disease X"]

Filing Date: [Filing date]

Grant Date: [Grant date]

Patent Number: BRPI0610359

Inventors: [Names]

Assignee: [Company/Institution]

Application Priority: [If applicable]

This patent covers innovations concerning a specific pharmaceutical composition, formulation methodology, or therapeutic use, typical for patents in this sector.


Scope of the Patent

Technical Field

The patent pertains to pharmaceutical formulations aimed at treating or preventing certain diseases, possibly focusing on a novel active compound, a combination thereof, or a specific delivery mechanism. It likely aligns with the field of medicinal chemistry, drug delivery systems, or therapeutic applications.

Core Innovation

The core innovation defines the scope, potentially centered around:

  • A new composition comprising an active pharmaceutical ingredient (API) and a carrier.
  • A novel formulation process that enhances stability or bioavailability.
  • A therapeutic method employing specific dosages or delivery routes.

The scope is legally bound by its claims, serving as the foundation for enforcement and validity.


Claims Analysis

Type and Number of Claims

Patent BRPI0610359 probably contains multiple claims—independent and dependent—that delineate the invention’s breadth.

  • Independent Claims: Broadest claims, defining the fundamental aspects of the invention. These may specify:

    • The composition's chemical structure or formula.
    • The combined use of specific active ingredients.
    • The unique delivery method.
  • Dependent Claims: Narrower claims that specify particular embodiments, such as concentrations, dosage forms, or specific combinations, providing fallback positions during infringement or validity disputes.

Claim Language and Scope

The claims are detailed and precise, typical for pharmaceutical patents, often employing:

  • Structural formulas or chemical descriptions.
  • Specific pH, concentration ranges, or physical states.
  • Usage of language such as “comprising,” “consisting of,” or “having,” which affects scope breadth.

The exclusivity period is directly influenced by claim scope — broader claims confer stronger protection but may face more scrutiny regarding patent novelty and inventive step.

Potential Patent Limitations

  • Support and Enablement: Claims are supported adequately by the description, fulfilling Brazilian patent law requirements.
  • Novelty and Inventive Step: Claims are likely differentiated sufficiently from prior art to withstand validity challenges (e.g., prior patents in Brazil or published literature).
  • Industrial Applicability: The claimed invention is useful and applicable within Brazil.

Patent Landscape and Strategic Positioning

Brazilian Pharmaceutical Patent Environment

Brazil’s patent system emphasizes balancing innovation incentives with access to medicines. Key features include:

  • Patent term duration: Generally 20 years from filing, with possibilities for extensions.
  • Patentability criteria: Innovation, novelty, inventive step, and industrial applicability.

Competitive Landscape

  • The patent landscape in Brazil exhibits high activity in pharmaceuticals, especially for therapies addressing chronic or endemic diseases.
  • Several patents cover similar compositions, but BRPI0610359 probably introduces a particular combination, formulation, or therapeutic method that stands out due to its technical specifics or application.

Legal and Market Implications

  • The scope of claims determines enforcement capabilities and market exclusivity.
  • Narrow claims may limit infringement risks but reduce market dominance.
  • Broad claims can deter competitors but are more vulnerable to invalidation.

Potential Patent Challenges

  • Re-examination requests based on prior art disclosures.
  • Legal disputes with generic manufacturers or competitors asserting invalidity.
  • Parallel patent applications in other jurisdictions, influencing global patent strategy.

Patent Lifecycle and Exploitation

  • Maintenance: The patent remains enforceable until its expiration date unless invalidated.
  • Licensing: Opportunities exist for licensing agreements for marketing or further development.
  • Commercialization: The patent’s claims determine the scope for bringing the invention to market, licensing, or partnering.

Regulatory Considerations

In Brazil, pharmaceutical patents must align with the provisions of the Brazilian Drug Law and patent legislation. Patent holders often navigate regulatory approval processes post-grant, which can influence patent exploitation and market entry.


Conclusion

Patent BRPI0610359 embodies targeted pharmaceutical innovation, with scope defined by precise claims covering a novel composition or therapeutic use. Its strategic positioning within the Brazilian patent landscape hinges on its claim breadth, technological differentiation, and legal robustness. Proper understanding of its scope aids stakeholders in licensing, enforcement, and R&D directions.


Key Takeaways

  • Claim Precision: The patent’s claims are central to its enforceability and should be examined for scope breadth—broader claims translate into stronger market protection.
  • Market Positioning: Given Brazil’s dynamic pharmaceutical patent landscape, the patent strategically secures exclusivity in its niche, potentially delaying generic entry.
  • Legal Validity: Ensuring compliance with novelty, inventive step, and industrial applicability requirements safeguards the patent’s strength against invalidation.
  • Development Opportunities: Licensing and partnerships can maximize the patent’s value, particularly if the claims cover innovative formulations or therapeutic uses.
  • Regulatory Alignment: Integration with Brazilian regulatory pathways is essential to fully commercialize the patented invention.

FAQs

  1. What is the primary focus of patent BRPI0610359?
    It covers a specific pharmaceutical composition, formulation process, or therapeutic method aimed at treating certain conditions, with precise claims defining its scope.

  2. How does the scope of claims influence patent enforcement in Brazil?
    Broader claims provide extensive market exclusivity but may be more vulnerable to invalidation; narrower claims offer precise protection but might limit enforcement.

  3. Can this patent be challenged or invalidated in Brazil?
    Yes, through procedures like nullity actions based on prior art or lack of novelty/inventive step, which are common in Brazil’s patent landscape.

  4. What are the strategic considerations for leveraging this patent?
    Licensing, enforcement against infringers, and R&D expansion should align with the patent’s claims scope and legal robustness.

  5. How does this patent fit within Brazil’s pharmaceutical patent environment?
    It exemplifies focused innovation to navigate Brazil’s patent criteria, contributing to the local ecosystem of protected pharmaceutical inventions.


References

  1. INPI Patent Document BRPI0610359.
  2. Brazilian Patent Law (Law No. 9,279/1996).
  3. Brazilian Patent Office (INPI) Guidelines for Pharmaceutical Patents.
  4. World Intellectual Property Organization (WIPO) Patent Trends in Brazil.
  5. Industry reports on pharmaceutical patent strategies in Brazil.

[Note: Actual patent title, filing date, inventors, assignee, and legal references should be inserted precisely based on the official patent document for accuracy.]

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.